FindTrial
Sign In

Vitamin D3 injection in warts.

Intralesional Vitamin D3 - An Immunotherapy in cutaneous warts.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020453
Enrollment
75
Registered
2019-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Intralesional vitamin D3-An Immunotherapy in cutaneous warts.: 0.2 ml of 6,00,000 IU Vitamin D3 was injected to the base of warts after injecting with 0.2 ml lignocaine.The injections w

Sponsors

DrRajitha alluri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with cutaneous warts 2.patients aged 15-60 years 3.Patients with no other treatment modalities in the past 3 months

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating females 2.Immunosupression including HIV 3.Any local or systemic inflammation or infection 4.Past history of meningitis o convulsions 5.plane warts 6.Genital warts 7.Patients with keloidal tendency. 8.Prior history of hypersensitivity to Vitamin D3 9.Previously diagnosed renal disease

Design outcomes

Primary

MeasureTime frame
Clearance of cutaneous warts at both primary and distant sites.Timepoint: 2,4,8 weeks—

Secondary

MeasureTime frame
1.Adverse effects of vitamin D3 injection. 2.Recuurence of cutaneous warts in patients treated with vitamin D3.Timepoint: 1. 8 Weeks 2. 6 months—

Countries

India

Contacts

Public ContactRajitha alluri

Guntur medical college

dr.rajithaalluri@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026